Skip to content
GLP-1 Decoder

Tirzepatide FDA Approvals: Every Indication and Date

Tirzepatide fda approval: what happened, what it means for patients, and where to read the record.

Active ingredient
tirzepatide
Manufacturer
Eli Lilly

Zepbound in brief

How long it remains in the body
100%50%25%0%05.5 d11 d16.5 d22 d27.5 d50%25%12.5%time after the dose

The half-life is 5 to 6 days. By 5.5 d, half is gone; after five half-lives (27.5 d), about 3% remains.

Amount of body weight lost in the main study
SURMOUNT-1: 5 mg weekly15%SURMOUNT-1: 10 mg weekly19.5%SURMOUNT-1: 15 mg weekly20.9%Placebo3.1%

For SURMOUNT-1 at 72 weeks, weight loss was 20.9% of body weight, while the placebo result was 3.1%.

Costs over time
202420252026$1,086.37$0List priceSelf-pay

Monthly prices in US dollars include list prices and self-pay offers. Each comes from the manufacturer's price page.

Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.

Related pages